GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TherapeuticsMD Inc (STU:29TA) » Definitions » Cyclically Adjusted PB Ratio

TherapeuticsMD (STU:29TA) Cyclically Adjusted PB Ratio : 0.15 (As of Jun. 07, 2024)


View and export this data going back to 2014. Start your Free Trial

What is TherapeuticsMD Cyclically Adjusted PB Ratio?

As of today (2024-06-07), TherapeuticsMD's current share price is €1.86. TherapeuticsMD's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €12.07. TherapeuticsMD's Cyclically Adjusted PB Ratio for today is 0.15.

The historical rank and industry rank for TherapeuticsMD's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:29TA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.14   Med: 1.15   Max: 19.77
Current: 0.16

During the past years, TherapeuticsMD's highest Cyclically Adjusted PB Ratio was 19.77. The lowest was 0.14. And the median was 1.15.

STU:29TA's Cyclically Adjusted PB Ratio is ranked better than
93.44% of 732 companies
in the Drug Manufacturers industry
Industry Median: 1.885 vs STU:29TA: 0.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

TherapeuticsMD's adjusted book value per share data for the three months ended in Mar. 2024 was €2.287. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €12.07 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


TherapeuticsMD Cyclically Adjusted PB Ratio Historical Data

The historical data trend for TherapeuticsMD's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TherapeuticsMD Cyclically Adjusted PB Ratio Chart

TherapeuticsMD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 12.52 1.22 0.37 0.16

TherapeuticsMD Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.28 0.21 0.16 0.17

Competitive Comparison of TherapeuticsMD's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, TherapeuticsMD's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TherapeuticsMD's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TherapeuticsMD's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where TherapeuticsMD's Cyclically Adjusted PB Ratio falls into.



TherapeuticsMD Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

TherapeuticsMD's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.86/12.07
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TherapeuticsMD's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, TherapeuticsMD's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.287/131.7762*131.7762
=2.287

Current CPI (Mar. 2024) = 131.7762.

TherapeuticsMD Quarterly Data

Book Value per Share CPI Adj_Book
201406 9.452 100.560 12.386
201409 15.815 100.428 20.752
201412 12.570 99.070 16.720
201503 23.472 99.621 31.048
201506 16.221 100.684 21.230
201509 19.434 100.392 25.510
201512 16.268 99.792 21.482
201603 41.953 100.470 55.025
201606 37.877 101.688 49.084
201609 33.167 101.861 42.908
201612 30.724 101.863 39.747
201703 25.973 102.862 33.274
201706 20.413 103.349 26.028
201709 28.974 104.136 36.665
201712 25.360 104.011 32.130
201803 20.090 105.290 25.144
201806 15.306 106.317 18.971
201809 24.321 106.507 30.091
201812 17.825 105.998 22.160
201903 11.134 107.251 13.680
201906 1.485 108.070 1.811
201909 -3.995 108.329 -4.860
201912 1.527 108.420 1.856
202003 -7.530 108.902 -9.112
202006 -15.342 108.767 -18.587
202009 -18.055 109.815 -21.666
202012 -17.001 109.897 -20.386
202103 -1.012 111.754 -1.193
202106 -5.155 114.631 -5.926
202109 -5.738 115.734 -6.533
202112 -9.637 117.630 -10.796
202203 -14.725 121.301 -15.997
202206 -2.783 125.017 -2.933
202209 -5.150 125.227 -5.419
202212 3.493 125.222 3.676
202303 3.133 127.348 3.242
202306 2.723 128.729 2.787
202309 2.486 129.860 2.523
202312 2.329 129.419 2.371
202403 2.287 131.776 2.287

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


TherapeuticsMD  (STU:29TA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


TherapeuticsMD Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of TherapeuticsMD's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


TherapeuticsMD (STU:29TA) Business Description

Traded in Other Exchanges
Address
951 Yamato Road, Suite 220, Boca Raton, FL, USA, 33431
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.

TherapeuticsMD (STU:29TA) Headlines

No Headlines